The deal marks the London-based firm’s seventh investment over the past year.
Following the acquisition, Fishawack will have the largest medical communications presence in Switzerland. It will also add to the company’s clinical and regulatory writing capabilities and drug safety work, said GCP.
GCP partner Simon Jobson said, “We invested in Fishawack as we recognised its strong potential for growth and international expansion. Acquisition is a key part of this strategy.
“The acquisition of Archimed will give Fishawack the largest medical communications team in Switzerland. It is the first step in management’s plan to build the company’s market leading position, increase its customer base and expands its geographic footprint.”
Earlier this week GCP backed ski and cruise agent Iglu.com’s acquisition of Planet Cruise, an online and TV cruise retailer.
Copyright © 2013 AltAssets